Coniflu-P
General Range

Coniflu-P

Novalab Healthcare Pvt. Ltd.Panchkula, Haryana

Price on request/100 · MOQ 100 boxes

Coniflu-P Capsules by Novalab Healthcare Pvt. Ltd. contain Flunarizine and Propranolol Hydrochloride (SR), a combination of medicines that may be prescribed for the preventive management of recurrent migraine headaches.

Flunarizine is a calcium channel blocker with antimigraine properties. It helps reduce susceptibility to migraine attacks through effects on neuronal excitability and calcium movement within cells.

Propranolol Hydrochloride is a non-selective beta-adrenergic blocker commonly used for migraine prevention. Its preventive effect involves modulation of pathways associated with migraine development. The sustained-release (SR) formulation is designed to release Propranolol gradually over time.

Coniflu-P Capsules may be prescribed for patients experiencing frequent or recurrent migraines when preventive treatment is considered clinically appropriate. The combination may help reduce migraine frequency and severity, although its suitability and effectiveness depend on individual patient factors.

Coniflu-P Capsules are not intended for immediate relief from an ongoing migraine attack. They should be taken strictly according to a registered medical practitioner's prescription.

CategoryGeneral Range
Min. Order100 boxes
Supplied byNovalab Healthcare Pvt. Ltd.
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Flunarizine & Propranolol Hydrochloride (SR) Capsules
Packaging Type
Capsules
Packaging Size
10 × 10
Dosage Form
Capsules
Treatment
Helps reduce the frequency of migraine episodes in selected patients.
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Novalab Healthcare Pvt. Ltd.Panchkula, Haryana
View Full Profile

Novalab Healthcare Pvt. Ltd. is an ISO-certified and WHO-GMP-compliant pharmaceutical company headquartered in Panchkula, Haryana, India, established around 2014.

Key Details

• Core Business: Offers PCD Pharma Franchise and third-party/contract manufacturing services across India.
• Leadership: Directed by CEO Mr. Pankaj Aggarwal / Agrawal.
• Product Range: Over 1,000 to 2,000 formulations spanning cardiac, diabetic, dermatology, pediatrics, gynecology, ophthalmology, critical care, Ayurvedic/herbal ranges, injectables, syrups, and protein powders.
• Services: Provides monopoly-based PCD franchise rights, marketing support, and nationwide distribution.
• Official Website: You can find more information on the Novalab Healthcare Official Website.
If you are looking for specific details—such as their product catalog, franchise terms, or contact information—let me know and I can help you find them.

More General Range